-
Study aim
-
The aim of this study is to evaluate the effect of synbiotics on constipation severity and stool consistency in adults with functional constipation.
-
Design
-
A clinical trial with parallel control and interventional groups, randomized (balanced blocked randomization), is performed on 180 patients.
-
Settings and conduct
-
Adult patients with functional constipation referred to Sari gastrointestinal clinics, after obtaining consent, will be asked about their demographic information and the status of primary constipation. patients randomly will receive an A or B package of drugs. Constipation is also recorded in follow-up.
-
Participants/Inclusion and exclusion criteria
-
Patients who have functional constipation according to the Rome (III) criterion and do not change their diet from normal during the study and are over 18 years of age are included in the study. Patients with depression, systemic diseases such as diabetes, and inflammatory bowel disease, constipation due to hypothyroidism and hypercalcemia, surgeries such as prostate, resection of the intestine, and spine surgery, recent weight loss, cancer need for colonoscopy, recent use of Laxatives, pregnancy, and lactation, alcohol and opium use, recent steroid use, anticholinergics, iron, and sulfasalazine will be excluded.
-
Intervention groups
-
Control group: standard treatment (15 gr of psyllium daily) for 30 days.
Intervention group: standard treatment and GeriLact Capsules (zist takhmir, Tehran, Iran) twice daily (half an hour before breakfast and dinner) for 30 days. GeriLact will be continued alone for another 15 days.
-
Main outcome variables
-
constipation severity and stool consistency